Sprint Bioscience AB
XMUN:5JA1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sprint Bioscience AB
XMUN:5JA1
|
SE |
|
C
|
Canon Marketing Japan Inc
XMUN:CNJ
|
JP |
|
S
|
Service Corporation International
XMUN:SVC
|
US |
|
T
|
TX Group AG
XBER:TAMN
|
CH |
|
A
|
Asia Plus Group Holdings PCL
SET:ASP
|
TH |
|
Guangdong Investment Ltd
F:GUG0
|
HK |
|
R
|
Resonac Holdings Corp
XMUN:SWD
|
JP |
|
Daimler Truck Holding AG
F:DTG1
|
DE |
Wall St Price Targets
5JA1 Price Targets Summary
Sprint Bioscience AB
According to Wall Street analysts, the average 1-year price target for 5JA1 is 0.308 EUR with a low forecast of 0.305 EUR and a high forecast of 0.317 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 5JA1's stock price target?
Price Target
0.308
EUR
According to Wall Street analysts, the average 1-year price target for 5JA1 is 0.308 EUR with a low forecast of 0.305 EUR and a high forecast of 0.317 EUR.
What is the Revenue forecast for Sprint Bioscience AB?
Projected CAGR
-19%
Over the last 12 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 3 years is -19%.
What is the Operating Income forecast for Sprint Bioscience AB?
Projected CAGR
-73%
The compound annual growth rate for Operating Income over the next 3 years is -73%.
What is the Net Income forecast for Sprint Bioscience AB?
Projected CAGR
-24%
The compound annual growth rate for Net Income over the next 2 years is -24%.
